The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 24900372 |
60 |
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia. |
TBA |
| 24900295 |
61 |
Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia |
TBA |
| 20724150 |
51 |
Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity. |
F. Hoffmann-La Roche |
| 19524438 |
38 |
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. |
Arena Pharmaceuticals |
| 18983141 |
11 |
Nicotinic acid receptor agonists. |
Arena Pharmaceuticals |
| 17804224 |
64 |
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. |
Arena Pharmaceuticals |
| 17358052 |
64 |
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b. |
Arena Pharmaceuticals |
| 25737085 |
26 |
Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists. |
Leiden University |
| 16480258 |
22 |
1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b. |
TBA |
Search and Browse
